Top Markets
Coin of the day
Apollomics, Inc. Apollomics, Inc.

Apollomics, Inc.

APLM
Ранг среди акций #25246
Apollomics, Inc., a biotechnology enterprise established in 2015 and... Apollomics, Inc., a biotechnology enterprise established in 2015 and headquartered in Foster City, California, conducts its research and development operations across California, Hangzhou, Shanghai, China, and Australia. The company is dedicated to discovering and advancing innovative oncology treatments to address critical unmet medical requirements. Its therapeutic pipeline features APL-101 (Vebreltinib), a potent and selective c-Met inhibitor being developed for non-small cell lung cancer and other advanced malignancies. Also in development is APL-102, an orally administered, small molecule multiple tyrosine kinase inhibitor intended for liver, breast, and esophageal cancers. Furthermore, APL-122 is an investigational tumor inhibitor candidate focused on treating cancers within the brain. The organization was formerly known as CBT Pharmaceuticals, Inc. before adopting the name Apollomics, Inc. in January 2019.
Цена акции
$23.57
Последняя синхронизация: 2026-08-20
Рыночная капитализация
$51.76M
Изменение (1 день)
-0.08%
Изменение (1 год)
289.59%
Страна
US
Торговля Apollomics, Inc. (APLM)

Категория

История дроблений акций Apollomics, Inc. (APLM)
Акции Apollomics, Inc. (символ: APLM) прошли через 0 дроблений.
Последнее дробление произошло Aug 21, 2026.
Одна акция APLM, купленная до Aug 21, 2026, сейчас соответствует 0 акциям APLM.
Список дроблений акций
Год Дробление Коэффициент Суммарный коэффициент
Недостаточно данных для указанных дат.
Дробления акций аналогичных компаний или конкурентов
Компания Количество дроблений акций Суммарный коэффициент Страна
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
US